For 17 years, Ken Jones fought fires in San Francisco. Now, he is fighting cancer -- and the insurance company that insures ...

The new artificial intelligence-based software and robot-assisted biopsy technology helps providers catch and treat lung cancer in its earliest stages.

Experts discuss the critical unmet needs in HER2-mutant non-small cell lung cancer, highlighting disparities in testing and ...

A retired firefighter with lung cancer is in a battle with his health insurance, and at a San Francisco hearing Thursday, his ...

Projected losses in Medicaid coverage as a result of President Trump's "One Big Beautiful Bill" could result in more than 1 million missed cancer screenings and hundreds of avoidable deaths within 2 ...

Merck begins phase 3 KANDLELIT-007 trial of calderasib in combo Keytruda QLEX in certain patients with advanced NSCLC: Rahway, New Jersey Friday, January 9, 2026, 15:00 Hrs [IST] ...

Merck is in talks to acquire Revolution Medicines in a deal that could value it at around $30 billion, according to people ...

Biomarker testing has become “increasingly critical” in the care of non-small cell lung cancer.A new investigation into testing rates proved “reassuring” to Kenneth L. Kehl, MD, MPH, assistant ...

In the same week that Servier announced its partnership with Paris, France-based Iktos, now Pierre Fabre Laboratories has ...

Chicago-based Northwestern Medicine has built one of the country’s most ambitious transplant programs. Whether performing the first double lung-liver transplant in the U.S., eliminating all traces of ...

Immunocore announces 2026 strategic priorities at 44th Annual J.P. Morgan Healthcare Conference Reaching more metastatic uveal melanoma patients with KIMMTRAK (tebentafusp) in 2026 through US ...

Parabilis Medicines raised $305 million in a Series F round led by RA Capital, Fidelity and Janus Henderson, with crossover ...